InnerVision was founded in 2002 with a mandate to improve healthcare through ‘world-changing’ biomedical diagnosis tools.
InnerVision Medical Technologies Inc. is a privately held technology company engaged in the research, development and commercialization of an ultra high resolution, acoustic based imaging system. Clinical validation trials and studies are underway worldwide and look promising.
InnerVision’s technology is a significant scientific breakthrough that combines novel techniques in acoustic wave analysis and the computational power of new age super computing. InnerVision’s leadership has leveraged many years of innovation In geophysics and applied to medical ultrasound imaging. InnerVision’s incorporates proprietary architecture and technology with four patents granted.
The system is a platform technology initially being developed for deep anatomical targets including obese, Ob/Gyn, cancer and other diagnosis.
InnerVision’s Board and Management are the principle investors in the company, and are stewarding InnerVision towards commercializing its technology.
